BOTULAX® (LETYBO®) 200u (Korean)

Description

Name: BOTULAX® 200u (Korean)
Manufacturer: Hugel Pharma
Active Substance(s): BOTULINUM TOXIN TYPE A
Strength: 200u
Pack Size: 1 Vial
Accessories: 1 x 200u Vial (Powder)

BOTULAX® 200u is a botulinum toxin type A injectable product used for both aesthetic and therapeutic treatments. It works by blocking acetylcholine release, which temporarily paralyzes targeted muscles, reducing wrinkles and treating muscle-related disorders. The product is commonly used for glabellar lines, crow’s feet, forehead lines, blepharospasm, and muscle spasticity. BOTULAX® 200u is manufactured under strict quality control measures, ensuring potency and stability. Clinical studies confirm its comparable efficacy and duration to other leading botulinum toxin brands​.

Key Features:

• High Purity and Stability – Strictly controlled potency with consistent effectiveness.
• Long-Lasting Effects – Results last 3-6 months, with peak improvement in 1-2 weeks.
• Global Availability – Registered in Korea, Thailand, Colombia, Chile, and expanding internationally​.

BOTULAX® 200u is supplied in a single-use vial, containing freeze-dried powder for reconstitution before injection.

Packaging Details:

• 200-unit vial in a sealed, sterile glass container.
• Tamper-proof packaging with holographic security labels.
• Requires reconstitution with sterile saline before use​.

Ingredients:

• Active Ingredient: Clostridium botulinum toxin type A – 200 Units per vial.
• Inactive Ingredients:
  • Human serum albumin (1.0 mg) – Stabilizer.
  • Sodium chloride (0.9 mg) – Maintains isotonicity​.

BOTULAX® 200u is used for both cosmetic and medical applications, providing targeted muscle relaxation.

Aesthetic Indications:

• Glabellar lines (frown lines) – 20 Units total, with 4 Units per injection site.
• Lateral canthal lines (crow’s feet) – 24 Units total, with 4 Units per site.
• Forehead lines – 40 Units total, combined with glabellar treatment​.

Medical Indications:

• Blepharospasm – Initial dose of 1.25 to 2.5 Units per site, injected into the orbicularis oculi muscle.
• Muscle spasticity – Individualized doses based on severity and patient response.
• Hyperhidrosis (excessive sweating) – 50 Units per underarm, injected in multiple sites​.

Contraindications:

• Hypersensitivity to botulinum toxin or formulation components.
• Active infection at the injection site.
• Neuromuscular disorders, such as myasthenia gravis or Lambert-Eaton syndrome​.

Common Side Effects:

• Glabellar lines: Eyelid ptosis (3%), mild redness, and swelling.
• Lateral canthal lines: Eyelid edema (1%), temporary discomfort.
• Forehead lines: Headache (9%), brow ptosis (2%)​.

BOTULAX® 200u is administered intramuscularly, following specific dosage recommendations.

Administration Guidelines:

• Glabellar lines – 20 Units total, with 4 Units per 5 injection points.
• Lateral canthal lines – 24 Units total, with 4 Units per 6 injection points.
• Forehead lines – 40 Units total, including glabellar treatment.
• Maximum total dose should not exceed 400 Units in 3 months​.

Storage Instructions:

• Unopened vials – Store at 2° to 8°C (36° to 46°F).
• After reconstitution – Use within 24 hours, keeping it refrigerated.
• Do not freeze or shake the product, as this may reduce efficacy​.

Warning! The product is intended solely for professional use in a medical environment and under professional supervision. The product is supplied to medical professionals who specialize in aesthetic medicine (plastic surgery, facial treatments) and work under individual medical licenses as aestheticians or in dedicated clinics. Unprofessional use by individuals without a medical background may lead to severe adverse effects and health harm.